Liquid Dosage
Insulin
With diabetes on the rise and the global insulin market estimated to be worth more than $32 billion by 2018, demand for GEA technologies for the production of this life-saving drug is already high and set to increase, particularly in new markets and emerging economies.
State-of-the-Art Solutions
GEA produces and supplies process systems for the production of liquid products for the pharmaceutical and biotechnological industries, and has a proven history of successfully installing plant for the production of insulin, including the engineering, delivery, commissioning and qualification of entire ultra-pure media systems as well as various process equipment and cleaning installations.
A worldwide technology leader in insulin production, GEA is able to supply the clean utility systems and manage the integration of all the main processes, including fermentation, harvesting, chromatography, filtration and freeze drying.
From Fermentation to Freeze Drying
The biosynthetic production of human insulin is done using bacteria or yeast cells. Following fermentation, or the conversion of chemical raw materials by micro-organisms, the biomass is extracted using a nozzle separator, washed, concentrated and finally precipitated to produce insulin crystals.
Centrifuges and process lines provided by GEA have an established pedigree in the clarification, separation, classification, concentration and fractionation steps. Nozzle separators also play an important part in the production process. Further, GEA chamber or self-cleaning separators can be used in the subsequent crystallization stages.
GEA is a single-source supplier of a variety of fermenters, media preparation, buffer storage, harvesting and cell rupture solutions, equipment for the purification and isolation of cells, separation (after both first and final crystallization), the production and distribution of WFI, CIP and freeze drying technologies, all of which can be installed and integrated into a state-of-the-art insulin production facility.
Productos y tecnologías
Mostrar 4 de 14
Bloque de compresión del homogeneizador
Los cabezales de compresión de GEA son el elemento central del homogeneizador puesto que bombean el producto a alta presión hasta que fluye por el interior de la válvula de homogeneización y de esta forma activan el proceso de homogeneización.
Bombas higiénicas
GEA Hilge ofrece una gama versátil de bombas centrífugas y de desplazamiento positivo para una amplia variedad de aplicaciones sensibles en las industrias de bebidas, alimentaria y farmacéutica.
Homogeneizadores de laboratorio
Los homogeneizadores de laboratorio de GEA son equipos pequeños y compactos que permiten comprobar los efectos de la homogeneización en el producto y determinar cuáles son los mejores parámetros del proceso.
Homogeneizadores industriales
Los homogeneizadores industriales de GEA son máquinas que constan de dos elementos fundamentales: un bloque de compresión que permite bombear el producto a alta presión y una válvula de homogeneización capaz de micronizar las partículas dispersas hasta que alcancen el tamaño de micrómetros y nanómetros, dependiendo de las características del prod...
Downloads
GEA Insights
Modern herd management: a smarter way to farm
In a dairy herd, every cow has her own story – and modern herd management tools help tell it. By tracking health, habits and needs, these smart systems let farmers care better, work smarter and keep milk flowing. It's the secret behind happy herds and successful, more sustainable dairy farming.
Alimentar el futuro: El poder de innovación de la liofilización
La reducción de residuos es importante para nosotros en GEA, y aprovechando el poder de la tecnología de liofilización, podemos transformar los excedentes de alimentos en productos valiosos y duraderos, ayudando a reducir sus residuos, prolongar la duración de almacenamiento y crear un suministro de alimentos más resistente para las generaciones venideras.
